| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $25.5M | +1749.8% |
| R&D Expense | $330.0M | +34.0% |
| SG&A Expense | $75.0M | +13.6% |
| Operating Income | -$373.0M | -24.6% |
| Income Tax | $0 | — |
| Net Income | -$342.0M | -17.7% |
| EPS (Basic) | -$2.79 | -7.7% |
| EPS (Diluted) | -$2.79 | -7.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $143.7M | -5.3% |
| Accounts Receivable | $306K | +0.0% |
| Current Assets | $770.1M | -24.5% |
| Total Assets | $844.0M | -23.3% |
| Current Liabilities | $30.3M | -52.5% |
| Total Liabilities | $92.0M | -38.5% |
| Stockholders' Equity | $752.0M | -20.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$300.3M | -30.9% |
| Capital Expenditures | $4.1M | -54.5% |
| Investing Cash Flow | $257.6M | +236.5% |
| Financing Cash Flow | $34.8M | -88.0% |
| Free Cash Flow | -$304.4M | -27.6% |